Mirati
is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer... Read moreMirati
is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer... Read more
News
Apr 03, 2024
The San Diego Union Tribune
Mirati: Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with this San Diego biotech
Mar 27, 2024
Endpoints News
Mirati: Bristol Myers to conduct layoffs at Mirati facility in California
Jan 25, 2024
Pharmabiz
Mirati: Bristol Myers Squibb completes acquisition of Mirati Therapeutics
Jan 13, 2024
Pharmabiz
Mirati: Mirati's Krazati gets European marketing nod for targeted treatment option for patients with advanced NSCLC with a KRASG12C mutation
Dec 26, 2023
Pharamceutical Technology
Mirati: MRTX-1719 by Mirati Therapeutics for Melanoma: Likelihood of Approval
Nov 13, 2023
Pharmabiz
Mirati: Mirati Therapeutics gets EMA Committee's positive opinion for Krazati as targeted treatment option for patients with advanced NSCLC with a KRASG12C mutation
Nov 10, 2023
PharmaLive
Mirati: Mirati's lung cancer drug gets EU's regulatory backing
Nov 08, 2023
MarketScreener
Mirati: MIRATI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
Nov 06, 2023
Owler
Mirati Therapeutics, Inc.: Mirati's revenue changed from $27.22M in Jun 2023 to $38.19M in Sep 2023
Nov 04, 2023
Pharmabiz
Mirati: Kura Oncology, Mirati Therapeutics ink clinical collaboration & supply agreement to evaluate KO2806 and adagrasib in KRASG12Cmutated NSCLC
Mirati Competitors
1
2
3
4
5
6
7
8
9
10